Lemme GLP-1: 2026 Honest Review
Lemme GLP-1 Daily is Kourtney Kardashian's supplement brand product. Despite the name, it is not a prescription GLP-1 medication and does not contain semaglutide, tirzepatide, or any GLP-1 receptor agonist. Here is what's actually in it, what the science says, and what a real prescription alternative looks like.
Last updated May 1, 2026.
Licensed providers · All 50 states · No insurance required
What Is Lemme GLP-1?
Lemme GLP-1 Daily is a dietary supplement (capsule and, in some markets, patch) sold direct-to-consumer. Its primary advertised ingredients are Saberry (an Indian gooseberry extract) and Eriomin (a lemon flavonoid). The product is marketed as supporting GLP-1 production.
Does Lemme Contain Semaglutide or Real GLP-1?
No. Lemme contains dietary supplement ingredients only. It does not contain semaglutide, tirzepatide, liraglutide, or any prescription GLP-1 receptor agonist. The name and marketing imply association with the GLP-1 medication category; the product is not in that category.
What Evidence Supports the Ingredients?
Saberry and Eriomin have small published studies, mostly manufacturer-funded, suggesting modest effects on metabolic markers. Independent evidence is limited. Effect sizes — where reported — are far smaller than prescription GLP-1 medications, which show 15–22% body weight reduction in trials.
Pricing
Lemme GLP-1 Daily retails at approximately $30–60 per month depending on subscription and retailer. Significantly less expensive than prescription GLP-1.
Lemme vs Real Prescription GLP-1
| Lemme GLP-1 Daily (supplement) | Compounded semaglutide (Rx) | Wegovy (brand Rx) | |
|---|---|---|---|
| Contains real GLP-1 medication | ✗ No (supplement) | ✓ Yes | ✓ Yes |
| FDA-approved drug | ✗ No | ✗ Compounded | ✓ Yes |
| Expected weight loss | Marginal | ~15% | ~15% |
| Cost per month | $30–60 | $199–399 | $1,300+ |
| Prescription required | No | Yes | Yes |
Licensed providers · All 50 states · No insurance required
Who Might Try Lemme
- People with BMI under 27 not eligible for prescription GLP-1
- People wanting a low-cost initial step
- Existing Lemme product users who like the brand
Who Shouldn't Bother
- People with BMI 30+ seeking meaningful weight loss — supplement effect won't match
- People expecting Ozempic-level results
- People with diabetes seeking glycemic control
Safety
Saberry and Eriomin are generally well tolerated in published studies. Like all supplements, ingredient quality is not FDA-enforced; manufacturer accountability for purity depends on internal QA. Discuss with your clinician if you take other medications.
Marketing Concerns
The product name implies GLP-1 medication. The FDA regulates "structure/function" supplement claims and prohibits unapproved drug claims. Several supplement brands have received warning letters for crossing the line; consumers should evaluate marketing language critically.